Cutler Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $279K | Sell |
10,075
-120,937
| -92% | -$3.36M | 0.09% | 216 |
|
|
2023
Q4 | $3.77M | Buy |
131,012
+39,367
| +43% | +$1.19M | 0.34% | 60 |
|
|
2023
Q3 | $3.04M | Buy |
91,645
+35,198
| +62% | +$1.24M | 0.31% | 56 |
|
|
2023
Q2 | $2.07M | Buy |
56,447
+34,537
| +158% | +$1.34M | 0.29% | 73 |
|
|
2023
Q1 | $893K | Sell |
21,910
-18,462
| -46% | -$797K | 0.09% | 220 |
|
|
2022
Q4 | $2.07M | Sell |
40,372
-20,263
| -33% | -$971K | 0.17% | 126 |
|
|
2022
Q3 | $2.65M | Buy |
60,635
+21,912
| +57% | +$1.06M | 0.18% | 108 |
|
|
2022
Q2 | $2.03M | Sell |
38,723
-170,002
| -81% | -$8.66M | 0.14% | 169 |
|
|
2022
Q1 | $10.8M | Buy |
208,725
+177,548
| +569% | +$9.21M | 0.57% | 17 |
|
|
2021
Q4 | $1.84M | Sell |
31,177
-104,257
| -77% | -$5.17M | 0.08% | 276 |
|
|
2021
Q3 | $5.83M | Buy |
135,434
+119,511
| +751% | +$5.29M | 0.26% | 67 |
|
|
2021
Q2 | $623K | Sell |
15,923
-18,390
| -54% | -$715K | 0.03% | 652 |
|
|
2021
Q1 | $1.24M | Sell |
34,313
-33,600
| -49% | -$1.19M | 0.06% | 358 |
|
|
2020
Q4 | $2.5M | Sell |
67,913
-35,789
| -35% | -$1.31M | 0.12% | 171 |
|
|
2020
Q3 | $3.61M | Buy |
103,702
+6,557
| +7% | +$230K | 0.22% | 84 |
|
|
2020
Q2 | $3.01M | Sell |
97,145
-1,823
| -2% | -$61.9K | 0.2% | 98 |
|
|
2020
Q1 | $3.06M | Buy |
98,968
+68,141
| +221% | +$2.32M | 0.16% | 120 |
|
|
2019
Q4 | $1.15M | Buy |
30,827
+26,262
| +575% | +$935K | 0.07% | 236 |
|
|
2019
Q3 | $155K | Buy |
4,565
+1,579
| +53% | +$57.4K | 0.01% | 826 |
|
|
2019
Q2 | $122K | Buy |
2,986
+2,143
| +254% | +$85.1K | 0.01% | 984 |
|
|
2019
Q1 | $33K | Sell |
843
-16,901
| -95% | -$677K | ﹤0.01% | 1706 |
|
|
2018
Q4 | $734K | Sell |
17,744
-4,848
| -21% | -$201K | 0.07% | 254 |
|
|
2018
Q3 | $944K | Sell |
22,592
-2,635
| -10% | -$101K | 0.07% | 283 |
|
|
2018
Q2 | $868K | Hold |
25,227
| – | – | 0.07% | 296 |
|
|
2018
Q1 | $849K | Sell |
25,227
-2,003
| -7% | -$68.9K | 0.07% | 259 |
|
|
2017
Q4 | $935K | Buy |
27,230
+1,476
| +6% | +$50.3K | 0.04% | 349 |
|
|
2017
Q3 | $872K | Buy |
+25,754
| New | +$828K | 0.03% | 400 |
|
|
2017
Q2 | – | Sell |
-3,162
| Closed | -$99.7K | – | 6887 |
|
|
2017
Q1 | $102K | Sell |
3,162
-128,330
| -98% | -$4.05M | ﹤0.01% | 1721 |
|
|
2016
Q4 | $4.05M | Buy |
131,492
+105,363
| +403% | +$3.22M | 0.15% | 110 |
|
|
2016
Q3 | $839K | Sell |
26,129
-14,338
| -35% | -$479K | 0.04% | 398 |
|
|
2016
Q2 | $1.35M | Sell |
40,467
-32,658
| -45% | -$1.04M | 0.07% | 215 |
|
|
2016
Q1 | $2.06M | Buy |
73,125
+14,744
| +25% | +$421K | 0.14% | 116 |
|
|
2015
Q4 | $1.79M | Buy |
+58,381
| New | +$1.84M | 0.1% | 192 |
|
Other funds holding PFE
Cutler Group's PFE Position: Q1 2024 in Review
Cutler Group reduced its Pfizer (PFE) stake by 92% in Q1 2024, selling an estimated $3.36M and leaving 10,075 shares worth $279K. The position accounts for 0.09% of the portfolio, ranked #216.
Cutler Group first reported a position in PFE in Q4 2015 and has held it in 33 quarters since. The position peaked at $10.8M in Q1 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Cutler Group held 10,075 shares of Pfizer worth $279K as of Q1 2024.
- Cutler Group sold 120,937 Pfizer shares in Q1 2024, an estimated $3.36M.
- Pfizer made up 0.09% of Cutler Group's portfolio in Q1 2024, its #216 holding.
- Cutler Group first reported a position in Pfizer in Q4 2015 and has held it in 33 quarters since.
- Cutler Group's Pfizer position peaked at $10.8M in Q1 2022.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.